Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
Abstract
Details
Title
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
Type of Article
Primary Research
Diets studied
SCD
Date
February 1, 2018
Author(s)
Suskind DL et al
Publication
Journal of Clinical Gastroenterology
Citation
Suskind, D. L., Cohen, S. A., Brittnacher, M. J., Wahbeh, G., Lee, D., Shaffer, M. L., Braly, K., Hayden, H. S., Klein, J., Gold, B., Giefer, M., Stallworth, A., & Miller, S. I. (2018). Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. Journal of Clinical Gastroenterology, 52(2), 155–163. https://doi.org/10.1097/MCG.0000000000000772
ISSN Number
0192-0790
Volume
52
Pages
155-163
SCD therapy in IBD is associated with clinical and laboratory improvements as well as concomitant changes in the fecal microbiome. Further prospective studies are required to fully assess the safety and efficacy of dietary therapy in patients with IBD.
Support our Mission
Your donation will help us to enhance the well-being and health outcomes of patients with IBD.
Donate